How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

White Papers
Supply Chain Integration of Merged and Acquired Entities
This paper shares the experience of a true and complete integration of supply chain in a mid-sized IDN under an accelerated timeline. The stud
On-Demand Educational Webinars
Supply Chain's Role in Non-Labor Expense Management (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Supply chain leaders share their processes and experiences in managing non-labor and non-personnel expenses.
On-Demand Educational Webinars
The Provider Perspective on Building Supply Chain Resiliency (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Provider panelists discuss their post-pandemic approach to their business continuity programs, working with non-traditional buyers, diversifying…
Podcasts
Sourcing Strategies During and After COVID-19
Michael Brown, Director of Supply Chain Management and Eric Swaim, Manager of Strategic Sourcing and Vendor Management at Texas Children’s Hospital…
Webcast
UDI Value in Recall Management
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r
Podcasts
Engaging Clinical Leadership in Supply Chain
Dr. Cherf, Chief Medical Officer at Lumere, and Dr.